2m 2m 2m 2m 2m 2m 2m
Intellia Therape (NTLA)
NASDAQ
$11.79+$0.04 (+0.38%)
Price as of Sep 11, 2026 7:49 PM EDT- $1.6BMarket Cap
- 2.80%1-Year Change
- BiotechnologyIndustry
Intellia Therape (NTLA)
$11.79+$0.04 (+0.38%)
Earnings Score
Valuation | NTLA | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -0 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | NTLA | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -6.21% | ||
12-Month Momentum | 5.87% | ||
3-Month Risk Adjusted Momentum | -18.03% | ||
12-Month Risk Adjusted Momentum | 6.05% |
True Yield
Valuation | NTLA | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | NTLA | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 1 |